Chemomab Therapeutics (CMMB) Accounts Payables (2017 - 2026)
Chemomab Therapeutics (CMMB) reported Accounts Payables of $257,000 for Q2 2026, down 32.0% from $378,000 a year earlier but up 26.0% from the prior quarter.
Powered by 
Analysis
Chemomab Therapeutics (CMMB) Accounts Payables (2017 - 2026) Analysis & Trends
At the end of FY2025, Chemomab Therapeutics posted Accounts Payables of $485,000, down 23.4% from FY2024.
- Accounts Payables has a five-year compound annual growth rate of 39.1% (FY2020 to FY2025).
- By year, Accounts Payables came in at $633,000 in FY2024 (+22.7%), $516,000 in FY2023 (-69.4%), $1.69 million in FY2022 (+26.3%) and $1.34 million in FY2021.
- Five-year quarterly Accounts Payables spans a low of $194,000 in Q3 2025 and a high of $2.35 million in Q2 2023.
- Year over year, Accounts Payables has now declined in each of the last six quarters, with an average decline of 32.6% over the last eight quarters.
- The high point for year-over-year Accounts Payables in five years was Q2 2022 (growth of 203.6%); the low point was Q1 2024 (a decline of 76.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $204,000 (Q1 2026), $485,000 (Q4 2025) and $194,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Accounts Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 9.22 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 33.30 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 3.83 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | 4.26 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | -22.89 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 2.87 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 674.00 Mn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 4.58 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 429.50 Mn |
| 10 | Chemomab Therapeutics | 8.56 Mn | 8.56 Mn | - | 257,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 257,000.00 |
| Mar 31, 2026 | 204,000.00 |
| Dec 31, 2025 | 485,000.00 |
| Sep 30, 2025 | 194,000.00 |
| Jun 30, 2025 | 378,000.00 |
| Mar 31, 2025 | 490,000.00 |
| Dec 31, 2024 | 633,000.00 |
| Sep 30, 2024 | 386,000.00 |
| Jun 30, 2024 | 1.11 Mn |
| Mar 31, 2024 | 527,000.00 |
| Dec 31, 2023 | 516,000.00 |
| Sep 30, 2023 | 731,000.00 |
| Jun 30, 2023 | 2.35 Mn |
| Mar 31, 2023 | 2.22 Mn |
| Dec 31, 2022 | 1.69 Mn |
| Sep 30, 2022 | 1.25 Mn |
| Jun 30, 2022 | 1.43 Mn |
| Mar 31, 2022 | 1.49 Mn |
| Dec 31, 2021 | 1.34 Mn |
| Sep 30, 2021 | 481,000.00 |
API Access
Chemomab Therapeutics Accounts Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accounts-payables&ticker=CMMB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accounts-payables", "ticker": "CMMB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=accounts-payables&ticker=CMMB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();